For the Inventor, By the Inventor

Enter inventor name

Wilmington, DE, United States of America

Paul Joseph Gilligan

USPTO Granted Patents = 47 (Patent Applications = 2)

CIPO Patents = 2

EPO Patents = 6 (Patent Applications = 4)

Average Co-Inventor Count = 3.2

ph-index = 13

Forward Citations = 637(Granted Patents)

Location History:

Wilimington, DE (US) (2001)
Wilmington, DE (US) (2000 - 2018)

Company Filing History:

19 out of 3,685

Bristol-myers Squibb Compnay

Bristol-myers Squibb Pharma Company

Dupont Pharmaceuticals Company

Dupont Pharmaceuticals, Inc.

Years Active: 2000-2018

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Factor XIa Inhibitors

Corticotropin Releasing Factor Antagonists

Corticotropin Releasing Factor Receptor Ligands

Dihydropyridone Compounds

Macrocycles

Cyclic P1 Linkers

Arylpropionamide Analogues

Pyrazolotriazines

Imidazo-Pyridines

Heterocyclic Compounds

Sulfonamide Bicyclic Compounds

Nitrogen Substituted Imidazoles

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9951071 - Dihydropyridone P1 as factor XIa inhibitors (2018-04-24),

2. 9902742 - Macrocycles as factor XIa inhibitors (2018-02-27),

3. 9611274 - Macrocycles as factor XIa inhibitors (2017-04-04),

4. 9409908 - Dihydropyridone p1 as factor XIa inhibitors (2016-08-09),

5. 9376444 - Dihydropyridone P1 as factor XIa inhibitors (2016-06-28),

6. 9221818 - Macrocycles as factor XIa inhibitors (2015-12-29),

7. 9108981 - Cyclic P1 linkers as factor XIa inhibitors (2015-08-18),

8. 8901115 - Cyclic P1 linkers as factor XIa inhibitors (2014-12-02),

9. 8604056 - Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors (2013-12-10),

10. 8367709 - Dipeptide analogs as coagulation factor inhibitors (2013-02-05),

11. 8252830 - Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors (2012-08-28),

12. 7842708 - Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors (2010-11-30),

13. 7678793 - Azolo triazines and pyrimidines (2010-03-16),

14. 7662817 - 4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands (2010-02-16),

15. 7626039 - Arylpropionamide, arylacrylamide, ayrlpropynamide, or arylmethylurea analogs as factor XIa inhibitors (2009-12-01),

Title: Paul Joseph Gilligan - Innovative Inventor from Wilmington

Introduction: Paul Joseph Gilligan is a renowned inventor based in Wilmington, Delaware, known for his groundbreaking contributions to various industries.

Latest Patents: Paul Joseph Gilligan holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of innovative ideas.

Career Highlights: With a career spanning over two decades, Paul Joseph Gilligan has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Paul Joseph Gilligan has collaborated with leading companies, research institutions, and universities to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Paul Joseph Gilligan's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of technology and beyond.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…